Cancer patients undergoing radiation therapy often suffer from acute radiation dermatitis, which can cause painful skin issues ranging from mild to severe, including blistering, open sores, and itching. However, two new studies offer hope for preventing and treating this condition. Researchers found that a common bacterium, Staphylococcus aureus (staph), maybe the culprit behind acute radiation dermatitis. When radiation weakens the skin structure, staph can break through and cause infections.
The researchers found chlorhexidine and mupirocin containing experimental antibacterial regimens to be effective in preventing severe symptoms in cancer patients undergoing radiation. Experts suggest that patients should ask their radiation oncologist about this regimen before treatment begins. The findings of the studies were published in JAMA Oncology.
Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.
Please login to comment on this article